ADTX
Aditxt, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.01
+7.35%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$24.4B
- Revenue estimate
- $1.0M
Latest reported
- Last report date
- May 20, 2026
- EPS actual
- -$2.06
- EPS estimate
- -$2.2B
- Revenue actual
- —
- Revenue estimate
- $1.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +35.6%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026